Songjiang Ma - Jan 2, 2025 Form 4/A - Amendment Insider Report for GYRE THERAPEUTICS, INC. (GYRE)

Role: President, Director
Signature: /s/ Songjiang Ma
Stock symbol: GYRE
Transactions as of: Jan 2, 2025
Transactions value $: -$9,871
Form type: 4/A - Amendment
Date filed: 1/10/2025, 04:01 PM
Date Of Original Report: Jan 6, 2025
Previous filing: Jan 2, 2025
Next filing: Jan 8, 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	GYRE	Common Stock	Sale	-$9.87K	-833	-0.03%	$11.85	2.92M	Jan 3, 2025	By Spouse	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id	Content
F1	This Form 4 amends the Form 4 filed on January 6, 2025 to reflect the correct transaction date as of January 3, 2025. The original filing incorrectly reported the transaction date as of January 3, 2024.